Sweden

(Click on the graphs under each topic) Diagnostic Substitution SWEDEN (Click on the graphs under each topic) AD Rate AD Changepoints Vaccines MMR Varicella N/A N/A Polio Hep A N/A Diagnostic Substitution Paternal Age Thimerosal N/A N/A N/A

Birth Year AD prevalence (%) Normalized AD* 1998 2003 2007 Go back to main page Birth Year AD prevalence (%) Normalized AD* 1998 0.12 0.23 2003 0.04 0.07 2007 0.52 1

(Click on the graphs under each topic) Go back to main page MMRII Vaccines (Click on the graphs under each topic) MMRII immunization coverage for Birthyear 1981 to 2008 MMRII coverage and AD prevalence in Sweden

MEASLES, MUMPS, RUBELLA, VARICELLA Data MMR main page Go back to main page MEASLES, MUMPS, RUBELLA, VARICELLA 1982 MMR II Combined measles, mumps and rubella with the RA 27/3 strain >=12 months Licensed

MMR main page Go back to main page Birthyear MMR coverage 1981 89.7 1982 91.1 1983 92.7 1984 93.6 1985 94.2 1986 94 1987 94.3 1988 94.7 1989 95.1 1990 95.7 1991 95.8 1992 96.2 1993 96.5 1994 96.8 1995 96.6 1996 96.3 1997 95.5 1998 1999 88.5 2000 90.5 2001 93.5 2002 94.5 2003 95.4 2004 2005 2006 96.7 2007 2008 96.4

MMR main page Go back to main page

POLIO VACCINES * There is no polio vaccine that uses MRC-5 cell line. Go back to main page POLIO VACCINES Cells Type of Vaccine Company Approval Trade Name Vero cell line   DTacP-IPV/Hib Sanofi Pasteur 1997 Pentaxim DTacP-IPV 1998 Tetraxim * There is no polio vaccine that uses MRC-5 cell line.